Pharmaceutical Manufacturing (NAICS 3254) generates occupational noise exposures that require mandatory OSHA 1910.95 hearing conservation programs at most facilities. Pharmaceutical manufacturing (NAICS 3254) is often perceived as a low-noise industry due to cleanroom environments. However, solid dose manufacturing (tablet presses, granulators, coating operations) According to CDC/NIOSH, approximately 22 million U.S. workers are exposed to hazardous occupational noise annually, and pharma workers are among those with significant hearing loss risk from primary production operations.
Soundtrace delivers in-house audiometric testing and noise monitoring for pharma operations — ANSI S3.1-compliant, automated STS detection, and licensed audiologist Professional Supervisor review.
Noise Levels by Process: NAICS 3254
| Equipment / Process | Typical Level | Typical 8-hr TWA | OSHA Status |
|---|---|---|---|
| Tablet press (high-speed rotary) | 85–100 dBA | 85–96 dBA | At or above action level; many exceed PEL |
| Fluid bed dryer / granulator | 85–95 dBA | 85–92 dBA | At or above action level |
| Coating pan | 80–90 dBA | 80–88 dBA | Monitor before assuming below AL |
| HVAC systems (mechanical rooms) | 85–100 dBA | 85–95 dBA | Maintenance staff exposure |
| Packaging lines (blister, bottle) | 85–95 dBA | 85–92 dBA | At or above action level |
| Cleanroom / sterile fill areas | 60–78 dBA | <80 dBA | Typically below action level |
| Purified water / WFI systems | 80–90 dBA | 80–88 dBA | Pump rooms may approach action level |
Pharmaceutical manufacturing (NAICS 3254) is often perceived as a low-noise industry due to cleanroom environments. However, solid dose manufacturing (tablet presses, granulators, coating operations) and packaging lines generate sustained noise levels at or above the OSHA action level. Mechanical rooms housing HVAC, purified water, and clean utilities are often the highest-noise environments on a pharma campus. OSHA enforcement data shows pharma manufacturers frequently lack comprehensive noise monitoring that characterizes all job classifications, particularly maintenance and engineering staff.
OSHA 1910.95 Compliance Requirements
All pharma workers at or above the 85 dBA action level must be enrolled in the full six-element OSHA 1910.95 hearing conservation program: noise monitoring, audiometric testing, hearing protection, training, recordkeeping, and access to information. Workers above the 90 dBA PEL also require a documented engineering controls assessment. See: audiometric testing for employers: complete guide.
OSHA Citation Patterns: NAICS 3254
| Violation Type | Frequency | Typical Penalty Range |
|---|---|---|
| Late or missing baseline audiograms (1910.95(g)(5)) | Very high | $2,000–$7,000 |
| Annual audiogram schedule failures (1910.95(g)(6)) | High | $2,000–$7,000 |
| No noise monitoring — assumed below action level without data (1910.95(d)) | High | $1,000–$5,000 |
| No engineering controls assessment above PEL (1910.95(b)(1)) | Moderate | $3,000–$9,000 |
| Inadequate HPD for actual exposure levels (1910.95(i)) | Moderate | $2,000–$6,000 |
| Missing or incomplete training records (1910.95(k)) | High | $1,000–$4,000 |
Workers’ Compensation Exposure
Pharmaceutical manufacturing workers in solid dose production develop occupational NIHL at rates comparable to other light manufacturing sectors. The challenge for WC defense is that pharma employers often assume sub-action-level exposure without conducting noise monitoring, leaving them without the documentation to defend against claims.
The primary defense tools: a pre-employment baseline audiogram establishing the worker's hearing at hire, continuous annual audiometric records with no gaps, noise monitoring documentation by job classification, and HPD provision and fit testing records. Without complete documentation, apportionment of hearing loss between employers or between occupational and non-occupational causes cannot be performed. See: workers’ compensation for occupational hearing loss.
Industry-Specific Considerations
FDA GMP requirements for pharmaceutical manufacturing create additional documentation and recordkeeping expectations that overlap with OSHA 1910.95 audiometric record retention. However, GMP records and OSHA audiometric records serve different purposes and must be maintained separately with appropriate access controls to comply with both 21 CFR Part 211 and OSHA 1910.95(m).
In-house audiometric testing for pharma operations
Soundtrace delivers OSHA-compliant audiometric testing and noise monitoring for pharma employers — automated STS detection, 30-year cloud retention, and licensed audiologist supervision.
Get a Free Quote Book a demo →